Efficacy of pazopanib and sunitinib in advanced axial chordoma: a single reference centre case series

BACKGROUND: Chordomas are rare malignant tumours of the axial skeleton and skull base supposed to arise from cellular remnants of the notochord. These tumours have the potential to metastasize (30–40 %), usually in the later course of the disease. However, the greatest morbidity is usually a result...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipplaa, Astrid, Dijkstra, Sander, Gelderblom, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088663/
https://www.ncbi.nlm.nih.gov/pubmed/27822356
http://dx.doi.org/10.1186/s13569-016-0059-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088663/
https://www.ncbi.nlm.nih.gov/pubmed/27822356
http://dx.doi.org/10.1186/s13569-016-0059-x

Ejemplares similares